| Literature DB >> 24826075 |
Abstract
The genus Listeria consists of a closely related group of Gram-positive bacteria that commonly occur in the environment and demonstrate varied pathogenic potential. Of the 10 species identified to date, L. monocytogenes is a facultative intracellular pathogen of both humans and animals, L. ivanovii mainly infects ungulates (eg., sheep and cattle), while other species (L. innocua, L. seeligeri, L. welshimeri, L. grayi, L. marthii, L. rocourtiae, L. fleischmannii and L. weihenstephanensis) are essentially saprophytes. Within the species of L. monocytogenes, several serovars (e.g., 4b, 1/2a, 1/2b and 1/2c) are highly pathogenic and account for a majority of clinical isolations. Due to their close morphological, biological, biochemical and genetic similarities, laboratory identification of pathogenic and nonpathogenic Listeria organisms is technically challenging. With the development and application of various molecular approaches, accurate and rapid discrimination of pathogenic and nonpathogenic Listeria organisms, as well as pathogenic and nonpathogenic L. monocytogenes strains, has become possible.Entities:
Keywords: Listeria; epidemic clone; identification; lineage; nonpathogenic; pathogenic; serovar
Year: 2013 PMID: 24826075 PMCID: PMC3987759 DOI: 10.4137/MBI.S10880
Source DB: PubMed Journal: Microbiol Insights ISSN: 1178-6361
L. monocytogenes serovars causing human listeriosis.*
| Serotype | No. of isolates (%) | Tendency to cause |
|---|---|---|
| 4b | 294/603 (49%) | CNS infections > M/N diseases > Bacteremia |
| 1/2a | 163/603 (27%) | Bacteremia > M/N diseases > CNS infections |
| 1/2b | 120/603 (20%) | M/N diseases > Bacteraemia > CNS infections |
| 1/2c | 22/603 (4%) | Bacteremia > CNS infections > M/N diseases |
| 3a/3b | 4/603 (<1%) | Bacteremia |
Adapted from Goulet et al33, which was based on the analysis of 603 L. monocytogenes isolates from 603 French patients during 2001–2003.
Abbreviations: M/N diseases, maternal-neonatal diseases; CNS infections, central nerve system infections.
Characteristics of L. monocytogenes lineages I–IV.*
| Lineage | Serovar | Rhamnose activity | PCR reactivity | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||
| ORF2819 | ORF2110 | |||||||||||
| I | 1/2b | + | + | + | + | + | + | + | + | − | − | − |
| 3b | + | + | + | + | + | + | + | + | − | − | − | |
| 4b | + | + | + | + | + | + | + | + | + | − | − | |
| 4d | + | + | + | + | + | + | + | + | + | − | − | |
| 4e | + | + | + | + | + | + | + | + | + | − | − | |
| II | 1/2a | + | + | + | + | + | + | + | − | − | + | − |
| 1/2c | + | + | + | + | + | + | + | − | − | + | + | |
| 3a | + | + | + | + | + | + | + | − | − | + | − | |
| 3c | + | + | + | + | + | + | + | − | − | + | + | |
| IIIA | 4a | + | + | + | − | − | − | − | − | − | − | − |
| 4c | + | + | + | − | + | −/+ | − | − | − | − | − | |
| IIIC | 4c | − | + | + | + | + | + | − | − | − | − | − |
| IV (IIIB) | 7 and unusual 4a,4b,4c | − | + | − | + | − | + | − | + | − | − | − |
Summarized from Liu et al36–39; Doumith et al54; Roberts et al.122
inlC is also found in some L. ivanovii strains.38
L. monocytogenes group-specific gene targets.
| Gene | Specificity | Reference |
|---|---|---|
| All | Liu et al | |
| All | Liu et al | |
| All | Liu et al | |
| All | Liu et al | |
| All | Liu et al | |
| All | Schaferkordt and Chakraborty | |
| All | Schaferkordt and Chakraborty | |
| All | Chen et al | |
| ORF2819 | Doumith et al | |
| ORF2110 | Doumith et al | |
| ORF2372 | Zhang and Knabel | |
| Doumith et al | ||
| Zhang and Knabel | ||
| Doumith et al | ||
| Gene region flanking | Borucki and Call | |
| Borucki and Call |
Listeria monocytogenes epidemic clones.
| Epidemic clone (EC) | Serovar | Ribotype | MVLST ST (VT) | Molecular marker | Outbreak involved | Reference |
|---|---|---|---|---|---|---|
| ECI | 4b | DUP-1038B | 20 | LMOf2365_2798 (AATAGAAATAAGCGGAAGTGT/TTATTTCCTGTCGGCTTAG) 303 bp | Nova Scotia, 1981 | Chen and Knabel |
| ECII | 4b | DUP-1044A | 19 | LMOh7858_0487.8 to | USA, 1998–1999 | Chen and Knabel |
| ECIII | 1/2a | DUP-1053A | 1 | LMOF6854_2463.4 (TTGCTAATTCTGATGCGTTGG/GCGCTAGGGAATAGTAAAGG) 497 bp | USA, 2000 | Chen and Knabel |
| ECIV (formerly ECIa) | 4b | DUP-1042B | 21 | Reactive with 4b-specific primers (ORF2110), but not with LMOf2365_2798 and LMOh7858_0487primers | Boston, 1979,1983 | Chen and Knabel |
| ECV | 1/2a | 59 | LM5578_2229 (TTGTTGAAGGAAGAGGTGGTC/TCTTTTCGGCTCATTTTCGT) 191 bp | Canada, 1988–2000 | Knabel et al |
Multi-virulence-locus sequence typing (MVLST) sequence types (Virulence Types, VTs) were assigned according to Chen et al.60
Sources: Chen Y, Zhang W, and Knabel SJ. J Clin Microbiol. 2007;45:835. Knabel SJ, et al. J Clin Microbiol. 2012;50:1748.